Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.

de Jonge E, Dekkers PE, Creasey AA, Hack CE, Paulson SK, Karim A, Kesecioglu J, Levi M, van Deventer SJ, van Der Poll T.

Blood. 2000 Feb 15;95(4):1124-9.

3.

Role of tissue factor pathway inhibitor in the regulation of tissue factor-dependent blood coagulation.

Golino P, Ragni M, Cimmino G, Forte L.

Cardiovasc Drug Rev. 2002 Winter;20(1):67-80. Review.

PMID:
12070535
4.

Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis.

Esmon CT.

Baillieres Best Pract Res Clin Haematol. 1999 Sep;12(3):343-59. Review.

PMID:
10856974
5.

The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia.

Levi M, van der Poll T, ten Cate H, van Deventer SJ.

Eur J Clin Invest. 1997 Jan;27(1):3-9. Review.

PMID:
9041370
7.

Activation of the contact and fibrinolytic systems after intravenous administration of endotoxin to normal human volunteers: correlation with the cytokine profile.

DeLa Cadena RA, Majluf-Cruz A, Stadnicki A, Agosti JM, Colman RW, Suffredini AF.

Immunopharmacology. 1996 Jun;33(1-3):231-7. Review.

PMID:
8856155
8.

TFPI-dependent activities of protein S.

Peraramelli S, Rosing J, Hackeng TM.

Thromb Res. 2012 May;129 Suppl 2:S23-6. doi: 10.1016/j.thromres.2012.02.024. Epub 2012 Mar 15. Review.

PMID:
22425215
9.

The coagulant response in sepsis and inflammation.

Levi M.

Hamostaseologie. 2010 Jan;30(1):10-2, 14-6. Review.

PMID:
20162247
10.

The role of natural anticoagulants in the pathogenesis and management of systemic activation of coagulation and inflammation in critically ill patients.

Levi M, van der Poll T.

Semin Thromb Hemost. 2008 Jul;34(5):459-68. doi: 10.1055/s-0028-1092876. Epub 2008 Oct 27. Review.

PMID:
18956286
11.

Thrombin, a link between coagulation activation and fibrinolysis.

Bertina RM, van Tilburg NH, de Fouw NJ, Haverkate F.

Ann N Y Acad Sci. 1992 Dec 4;667:239-48. Review. No abstract available.

PMID:
1309042
12.

Human models of endotoxemia and recombinant human activated protein C.

O'Brien JM Jr, Abraham E.

Crit Care Med. 2004 May;32(5 Suppl):S202-8. Review.

PMID:
15118518
13.

[Blood coagulation and fibrinolysis].

Kienast J, Ostermann H.

Z Kardiol. 1993;82 Suppl 2:65-9. Review. German.

PMID:
8328211
14.

Coagulation inhibitor substitution during sepsis.

Fourrier F, Jourdain M, Tournois A, Caron C, Goudemand J, Chopin C.

Intensive Care Med. 1995 Nov;21 Suppl 2:S264-8. Review.

PMID:
8636534
15.

[Correlation between intravascular coagulation/fibrinolysis system and cytokines].

Shinozawa Y, Xie XQ, Endo T, Takuma K, Koike K.

Nihon Rinsho. 2004 Dec;62(12):2253-61. Review. Japanese.

PMID:
15597792
16.

Platelet tissue factor pathway inhibitor modulates intravascular coagulation.

Maroney SA, Mast AE.

Thromb Res. 2012 May;129 Suppl 2:S21-2. doi: 10.1016/j.thromres.2012.02.023. Epub 2012 Mar 17. Review.

17.

Role of altered coagulation-fibrinolytic system in the pathophysiology of diabetic retinopathy.

Behl T, Velpandian T, Kotwani A.

Vascul Pharmacol. 2017 May;92:1-5. doi: 10.1016/j.vph.2017.03.005. Epub 2017 Mar 31. Review.

PMID:
28366840
18.

Coagulation in patients with severe sepsis.

Levi M, Poll Tv.

Semin Thromb Hemost. 2015 Feb;41(1):9-15. doi: 10.1055/s-0034-1398376. Epub 2015 Jan 15. Review.

PMID:
25590524
19.

Inhibition of extrinsic coagulation activation in endotoxemia; therapeutic implications.

ten Cate H, Levi M, van der Poll T, Biemond BJ, van Deventer SJ, Buller HR, ten Cate JW.

Prog Clin Biol Res. 1994;388:215-9. Review. No abstract available.

PMID:
7831360
20.

Therapeutic applications of antithrombin concentrates in systemic inflammatory disorders.

Fourrier F.

Blood Coagul Fibrinolysis. 1998 Apr;9 Suppl 2:S39-45. Review.

PMID:
9662468

Supplemental Content

Support Center